Screener
Glaukos GKOS R&D
R&D at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Glaukos in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Glaukos’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324201
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Gross profit | 151,594 | 97,224 | 268,826 | 179,572 |
| Operating expenses: | ||||
| Selling, general and administrative | 116,060 | 83,375 | 209,003 | 154,048 |
| Research and development | 51,301 | 36,538 | 95,446 | 68,891 |
| Acquired in-process research and development | 1,500 | - | 1,500 | - |
| Total operating expenses | 168,861 | 119,913 | 305,949 | 222,939 |
| Loss from operations | (17,267) | (22,689) | (37,123) | (43,367) |
| Non-operating income (expense): |
Item 1. Financial Statements
FAQ
- What is Glaukos's R&D?
- Glaukos (GKOS) reported R&D of $51.3M in Q2 2026.
- How has Glaukos's R&D changed year-over-year?
- Glaukos's R&D increased by 40.4% year-over-year, from $36.54M to $51.3M.
- What is the long-term trend for Glaukos's R&D?
- Over 4 years (2021 to 2025), Glaukos's R&D has grown at a 10.5% compound annual growth rate (CAGR), from $101M to $150.61M.
- What does R&D mean?
- Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.
Ask your AI about Glaukos's r&d.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude